Additionally, this study reveals a previously unappreciated utility of PIM kinase inhibition in reducing S100A8/A9 expression and secretion and tumor infiltration of immunosuppressive myeloid cells in an S100A8/A9-dependent and -independent manner. Here, IGKV1D-22 is linked to neoplasm.